Cloning and characterization of spliced fusion transcript variants of synovial sarcoma: SYT/SSX4, SYT/SSX4v, and SYT/SSX2v. Possible regulatory role of the fusion gene product in wild type SYT expression
Authors:
- Karl HaslamKHKarl Haslam
- Ke YangKYKe Yang
- Armando BartolazziABArmando Bartolazzi
- Yuntao XieYXYuntao Xie
- Maria StarborgMSMaria Starborg
- Joakim LundebergJLJoakim Lundeberg
- Olle LarssonOLOlle Larsson
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- p300 Interacts with the Nuclear Proto-Oncoprotein SYT as Part of the Active Control of Cell AdhesionCell, 2000
- Delineation of the Protein Domains Responsible for SYT, SSX, and SYT-SSX Nuclear LocalizationExperimental Cell Research, 2000
- A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomasOncogene, 1998
- Conjunction dysfunction: CBP/p300 in human diseaseTrends in Genetics, 1998
- SSX: A multigene family with several members transcribed in normal testis and human cancerInternational Journal of Cancer, 1997
- Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteinsHuman Molecular Genetics, 1997
- The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodiesHuman Molecular Genetics, 1997
- Truncated WT1 mutants alter the subnuclear localization of the wild-type protein.Proceedings of the National Academy of Sciences, 1995
- Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcomaNature Genetics, 1994
- Molecular cloning of the synovial sarcoma-specific translocation (X;18)(p11.2;q11.2) breakpointHuman Molecular Genetics, 1994